Boston Scientific (BSX) Institutional Ownership
13F filers reported holding 97.1% of Boston Scientific (BSX) shares as of Sep 30, 2026, across 1,509 filers.
- Held by 13F filers
- 97.1%
- Sep 30, 2026
- 13F filers
- 1,509
- quarter ended Sep 30, 2026
- 13F value
- $61.5B
- 1.4B shares
- Quarter's fund flow
- Mild accumulation
- 229 new · 171 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Mahoney Michael F | Chairman, President & CEO | Acquired · Gift | 149,992 | — | ↗ |
| Nov 4, 2026 | Mahoney Michael F | Chairman, President & CEO | Acquired · Gift | 102,249 | — | ↗ |
| Nov 1, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | Acquired · Option exercise | 3,871 | — | ↗ |
| Nov 1, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | Disposed · Tax withholding | 1,872 | $41.98 | ↗ |
| Nov 1, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | Disposed · Option exercise | 3,871Restricted Stock Units | — | ↗ |
| Sep 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | Acquired · Option exercise | 1,171 | — | ↗ |
| Sep 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | Disposed · Tax withholding | 567 | $48.37 | ↗ |
| Sep 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | Disposed · Option exercise | 1,171Restricted Stock Units | — | ↗ |
| Aug 25, 2026 | Morano Susan E | director | Acquired · Open-market buy | 2,040 | $49.22 | ↗ |
| Aug 11, 2026 | Woodworth Emily | SVP, Global Controller and CAO | Acquired · Discretionary | 2,930 | $51.19 | ↗ |
| Aug 10, 2026 | Monson Jonathan | EVP and CFO | Acquired · Discretionary | 9,908 | $50.46 | ↗ |
| Aug 5, 2026 | Habiger David C | director | Acquired · Open-market buy | 2,100 | $47.59 | ↗ |
| Aug 4, 2026 | Habiger David C | director | Acquired · Open-market buy | 140 | $48.59 | ↗ |
| Aug 3, 2026 | Habiger David C | director | Acquired · Open-market buy | 1,042 | $48.07 | ↗ |
| Aug 3, 2026 | Mahoney Michael F | Chairman, President & CEO | Acquired · Open-market buy | 186,240 | $48.33 | ↗ |
| Aug 3, 2026 | Mahoney Michael F | Chairman, President & CEO | Acquired · Discretionary | 22,119 | $48.43 | ↗ |
| Jul 31, 2026 | LUDWIG EDWARD J | director | Acquired · Open-market buy | 5,000 | $45.48 | ↗ |
| Jul 31, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Acquired · Discretionary | 64,198 | $46.73 | ↗ |
| Jul 1, 2026 | Monson Jonathan | EVP and CFO | Acquired · Option exercise | 2,087 | — | ↗ |
| Jul 1, 2026 | Monson Jonathan | EVP and CFO | Disposed · Tax withholding | 1,010 | $43.06 | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Boston Scientific do institutions hold?
13F filers reported holding 97.1% of Boston Scientific's shares as of Sep 30, 2026, across 1,509 filers.
How many 13F filers hold Boston Scientific?
Boston Scientific was held by 1,509 13F filers as of Sep 30, 2026.
Not investment advice.

